Novel coating for stents could lower odds of blood clotting

09/9/2013 | PhysiciansBriefing.com

A study in Arteriosclerosis, Thrombosis, and Vascular Biology found that coating stents with CTP synthase 1 inhibitors such as cyclopentenyl cytosine may help inhibit smooth muscle cell proliferation, potentially cutting the risk of blood clots. "Our study identified CTPS1 as a novel target for developing anti-neointima drugs that are SMC-sensitive but have little side-effect on re-endothelialization during vascular repair," researchers said.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN